Comparative short-term risks of infection and serious infection in patients receiving biologic and small-molecule therapies for psoriasis and psoriatic arthritis: a systemic review and network meta-analysis of randomized controlled trials

CONCLUSION: This NMA provides a comprehensive assessment of the comparative short-term risks of infection, which could help physicians and patients to select individualized treatments for psoriasis.REGISTRATION: CRD42022359873.PMID:37901688 | PMC:PMC10612457 | DOI:10.1177/20406223231206225

Source: Adv Data - October 30, 2023 Category: Epidemiology Authors: Hsien-Yi Chiu Yi-Teng Hung Yu-Huei Huang Source Type: research